Cite
Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide.
MLA
Xiao, Gu, et al. “Targeting Triple Negative Breast Cancer with a Nucleus-Directed P53 Tetramerization Domain Peptide.” Molecular Pharmaceutics, vol. 18, no. 1, Jan. 2021, pp. 338–46. EBSCOhost, https://doi.org/10.1021/acs.molpharmaceut.0c00978.
APA
Xiao, G., Annor, G. K., Fung, K., Keinänen, O., Zeglis, B. M., & Bargonetti, J. (2021). Targeting Triple Negative Breast Cancer with a Nucleus-Directed p53 Tetramerization Domain Peptide. Molecular Pharmaceutics, 18(1), 338–346. https://doi.org/10.1021/acs.molpharmaceut.0c00978
Chicago
Xiao, Gu, George K Annor, Kimberly Fung, Outi Keinänen, Brian M Zeglis, and Jill Bargonetti. 2021. “Targeting Triple Negative Breast Cancer with a Nucleus-Directed P53 Tetramerization Domain Peptide.” Molecular Pharmaceutics 18 (1): 338–46. doi:10.1021/acs.molpharmaceut.0c00978.